TOP STORIES
respiratory
Medicines

Biologic effective in patients with chronic rhinosinusitis with nasal polyps


Mepolizumab reduces nasal polyp size and obstruction in patients with severe chronic rhinosinusitis, results from a large international study suggest. Researchers found that the anti-IL-5 biologic reduced the need for repeat nasal surgery and cut the use of systemic corticosteroids. Patients...

Mepolizumab reduces nasal polyp size and obstruction in patients with severe chronic rhinosinusitis, results from a large international study suggest. Researchers...

Read more